Table 1.
Demographic and epidemiologic characteristics of the enrolled Omicron variant‐infected patients and healthy donors receiving the SARS‐CoV‐2 vaccine
| Variables (n [%] or median [IQR]) | Vaccinated HDs (n = 60) | OIPs (n = 77) | p Value | Pre‐vaccinated OIPs (n = 68) | Unvaccinated OIPs (n = 9) | p Value |
|---|---|---|---|---|---|---|
| Age (years) | 38 (29–50) | 39 (29–53) | 0.668 | 40 (30.25–53） | 30 (12–54.5) | 0.086 |
| Sex | ||||||
| Female | 28 (46.6%) | 38 (49.3%) | 0.755 | 33 (48.5%) | 5 (55.5%) | 0.692 |
| Male | 32 (53.3%) | 39 (50.6%) | 35 (51.4%) | 4 (44.4%) | ||
| Ct value of RT‐PCR | 29.5 (24.25–32) | 29.5 (24.25–32) | 29 (23.5–39.42) | 0.898 | ||
| Severity | ||||||
| Asymptomatic | 25 (32.47%) | 25 (36.76%) | 0 | 0.027 | ||
| Symptomatic | 52 (67.53%) | 43 (63.24%) | 9 (100%) | |||
| Mild | 48 (62.34%) | 40 (58.82 | 8 (88.89%) | |||
| Moderate | 4 (5.19%) | 3 (4.41%) | 1 (11.11%) |
Abbreviations: Ct, cycle threshold; HD, healthy donor; IQR, interquartile range; OIP, Omicron variants‐infected patient; RT‐PCR, reverse transcription‐polymerase chain reaction.